Evasc Neurovascular Announces First Neuro Product Approved in French Forfait Innovation Program
Evasc Neurovascular is proud to announce its successful application to France’s Ministry of Health (Haute Autorité de la Santé, HAS) Forfait Innovation (FI) program for the eCLIPs™ device, published in its official journal December 23, 2020 - https://www.legifrance.gouv.fr/jorf/id/JORFTEXT000042722732 .
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210222005015/en/
The Forfait Innovation program grants clinical trial funding to evaluate CE marked devices that are deemed to be truly innovative (not simply incremental developments) and offer significant clinical benefit, filling an unmet medical need. The eCLIPs device is the first neuro device that has gained FI approval and funding. The funded amount of €2.76 million covers hospital costs of a 119-patient trial against optimal performance criteria (OPC).
Dr. Donald Ricci, CEO of Evasc Neurovascular, comments, “We are pleased to have confirmation by an influential and independent third party, the French Ministry of Health, that eCLIPs represents an innovation in the treatment of intracranial bifurcation aneurysms, a consistent message in our presentations, publications and discussions with neuro-interventionalists over the past few years.”
About the eCLIPs Aneurysm Treatment System
eCLIPs is a non-tubular endovascular device currently targeted for use in challenging wide-neck bifurcations, using technology designed to treat 95% of cerebral aneurysm cases. The unique eCLIPs design provides not only coil retention, but also flow diversion at the neck. eCLIPs avoids dangerous entry into the dynamic, fragile environment of the aneurysm sac while leaving side branches unencumbered and providing a platform for endothelial growth across the bifurcation neck.
About Evasc Neurovascular
Evasc Neurovascular is a privately-held medical device company focused on the development of disruptive endovascular treatments for cerebral aneurysms. Evasc Neurovascluar is headquartered in Vancouver, Canada.
Visit Evasc Neurovascular at www.evasc.com .
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OR-AIRSHIP8.3.2021 10:02:11 CET | Press release
Laura Schwarz Moves Up at Airship
SABIO-GROUP8.3.2021 10:02:11 CET | Press release
Sabio Group Acquires makepositive, Expanding Focus on Customer Relationship Management
GN-CORPORATION8.3.2021 09:22:06 CET | Press release
Cell Therapy for Cartilage Regeneration Gets a Boost With Hyaluronic Acid Enriched Chondrocytes in a 3D Tissue Engineering Platform
KAPSCH-TRAFFICCOM8.3.2021 09:12:04 CET | Press release
Norway Starts Free-Flow Tolling In One Of World´s Deepest Undersea Tunnels - Kapsch TrafficCom reports
NORTHERN-DATA-AG8.3.2021 09:05:13 CET | Press release
Northern Data closes acquisition of data center site in Northern Sweden and continues successful expansion driven by enormous demand
NY-PHILIP-MORRIS-INTL8.3.2021 09:05:12 CET | Press release
Philip Morris International Announces Yearlong Exploration of Inclusion—Furthering the Company’s Commitment to Equality
EXCELYA8.3.2021 09:02:09 CET | Press release
Nathalie Doize Appointed Director of Operations - Rudolph Rosenberg Appointed Chief Financial Officer
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom